LoginRegister
    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in USSun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US
    Biocon arm Syngene names Sibaji Biswas as new Chief Financial OfficerBiocon arm Syngene names Sibaji Biswas as new Chief Financial Officer
    Suven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpointSuven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpoint
    China plans to use bulk-buy scheme to close pharmaceutical price gapChina plans to use bulk-buy scheme to close pharmaceutical price gap
    Materiovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug ControllersMateriovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug...
    SCHOTT introduces new glass tank facility at Gujarat plantSCHOTT introduces new glass tank facility at Gujarat plant
    Eli Lilly to invest USD 400 million in Indianapolis facilitiesEli Lilly to invest USD 400 million in Indianapolis facilities
    Bayer collaborates with Pharmaron to develop new molecular entities for veterinary medicinesBayer collaborates with Pharmaron to develop new molecular entities for veterinary medicines
    Neuraxpharm expands operation in Southern Europe with launch of Neuraxpharm PortugalNeuraxpharm expands operation in Southern Europe with launch of Neuraxpharm Portugal
    Health Ministry appoints 12 analysts pan India for different classes of drugs; DetailsHealth Ministry appoints 12 analysts pan India for different classes of drugs; Details
    MTaI to work closely with DoP, Invest India to promote investments in medical device sectorMTaI to work closely with DoP, Invest India to promote investments in medical device sector
    Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 croreAurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X